Tag
Tag: HIV
Update: Cancer Immunotherapy Biotech Files for Insolvency
ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV
Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III
HIV Drug Suppresses Virus for Almost Two Years When Other Treatments Fail
7 Diseases CRISPR Technology Could Cure
EU Approves Two-Drug Pill as First-Line Treatment for HIV
This Biotech Reduces Drug Side Effects Using Silica Gel Implants
How Vaccines Could One Day Beat HIV
‘CRISPR Babies’ Might Be at Risk of Dying Younger
Update: Two-Drug HIV Treatment Effective for up to Three Years
